JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Issues journals
Medical Radiology and Radiation Safety. 2019. Vol. 64. No. 2. P. 5–10
DOI: 10.12737/article_5ca58d9b366162.17322538
V.V. Uiba1, Yu.D. Udalov2, A.O. Lebedev2, L.I. Shulepova3
Prospects for Implementing of Technologies of Nuclear Medicine in the FMBA of Russia
1. Federal Medical Biological Agency, Moscow, Russia;
2. A.I. Burnasyan Federal Medical Biophysical Center, Moscow, Russia. E-mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
,
This email address is being protected from spambots. You need JavaScript enabled to view it.
3. Federal High-Tech Center for Medical Radiology of Federal Medical Biological Agency, Dimitrovgrad, Russia
V.V. Uiba – Head of the Federal Medical Biological Agency of Russia, Dr. Sci. Med, Prof.;
Yu.D. Udalov – Deputy Director General, PhD Med.;
A.O. Lebedev – Deputy Head of Dep.;
L.I. Shulepova – Director General
Abstract
The article is devoted to development prospects of nuclear medicine in the Russian Federation. One of the first to provide nuclear medicine in Soviet Union was A.I. Burnasyan. He headed the 3d Directorate General of Ministry of Health (the FMBA of Russia at present). The Institute of Biophysics and the Institute of Medical Radiology (Obninsk), was established in the 50s – 60s of the 20th century, laid the foundation for nuclear medicine and developed it. With their efforts, nuclear medicine in USSR has become the world leader. However, in the 1980s – 1990s, there was a serious lag in this area due to radiophobia that arose after the Chernobyl accident, as well as the collapse of the USSR and the severe economic crisis, overcoming which in the beginning of the 21st century made it possible to pay considerable attention to nuclear medicine. Today the FMBA of Russia leads in the development and application of nuclear medicine technology. In the departments of the FMBA of Russia – the Siberian Research and Clinical Center (Krasnoyarsk) and Northern Medical Clinical Center N.A. Semashko (Arkhangelsk) – carries out high-tech diagnostics and treatment of cancer, neurological and cardiac diseases. Currently, in Dimitrovgrad city, the creation of the Federal High-Tech Center for Medical Radiology of the FMBA of Russia (FHCMR, FMBA of Russia) under the state program “Establishment of Federal Centers of Medical Radiological Technologies” is being completed. FHCMR, FMBA of Russia will provide high-tech medical care to the assigned contingent of the FMBA of Russia and the adult population of the Central, Volga, North-West federal districts. In the article noted the need for training specialists in the nuclear medicine. Training of specialists is already being conducted at the Training and Education Center of the Federal Siberian Research and Clinical Center of the FMBA of Russia. An important aspect of the introduction of nuclear medicine technologies and the operation of such centers are issues of legal regulation. The article pays attention to the licensing of nuclear medicine objects in accordance with the requirements of the Federal Law No. 170-FZ of November 21, 1995 “On the Use of Atomic Energy”. The tasks that need to be addressed for the development of nuclear medicine technologies are formulated, including through the implementation of the public-private partnership mechanism, as well as by expanding international cooperation with the EAEU member states.
Key words: nuclear medicine, proton beam therapy, radiation therapy, proton therapy center, radiopharmaceuticals
REFERENCES
1. Zabelin MV, Klimanov VA, Galyautdinova JJ, Samoylov AS, Lebedev AO, Shelyhina EV. Proton radiation therapy: clinical application opportunities and research prospects // Research’n Practical Medicine Journal. 2018;5(1):82-95. DOI: org/10.17709/2409-2231-2018-5-1-10. (Russian).
2. Klimanov VA, Zabelin MV, Galyautdinova JJ. Proton radiotherapy: current status and future prospects // Medical Physics. 2017;(2):89-121. (Russian).
3. Zhykova A. Rays of life // Review proton therapy. Thematical Annex to «Kommersant» Magazine. 2017;97:18-9. (Russian).
4. Zheltova VV. Developments prospects of nuclear medicine in medical cluster. Report on the 1-st International Scientific Conference “Medical Radiology”. 2012. (Russian).
5. Tripoten E. Nuclear medicine: the long game [Electronic resource]: http://www.atomiexpert.com/nucmed (date of the application 15.10.2018). (Russian).
6. Romanova S. Nuclear medicine: current status and development prospects. Remedium magazine. 2015;(8):8-20. (Russian).
7. Fergman A. Tendency and long-term prospects for practical application nuclear technologies in medicine. Report on the meeting of the Skolkovo Foundation. 2013. (Russian).
8. Horoshkov VS. Proton radiotherapy in ITEP (1964-2015). Report on the meeting of the ITEP. 2015. (Russian).
9. Dubinkin DO. About harmonization of requirements of radiation safety for the development of nuclear medicine in Russia // Rep. Internat. Sci. Conf. Current Issues of the Radiation Hygiene. 2014. (Russian).
10. Korsunsky VN, Codina GE. Analysis of the state and prospects of development of nuclear medicine in Russia // Report on the Forum of Innovation in Nuclear Medicine in Obninsk. 19 May, 2011. (Russian).
11. Uiba VV. Report during the latest enlarged meeting of the FMBA of Russia [Electronic resource]: http://www.fmbaros.ru/Public/SimplePage/2288 (date of the application 15.10.2018). (Russian).
12. Subramanian S. It’s time for Russia to being nuclear power // Report on the X Intern. Forum Dedicated 70-th Anniversary of Atomic Industry. Intergenerational dialogue [Electronic resource]: URL:http://www.osatom.ru/mediafiles/u/files/X_forum_2015/17_Soma_NUCLEAR_MED_SUPERPOWER.pdf (date of the application 15.10.2018). (Russian).
13. Plan of the Development a Nuclear Medicine Centers Until 2021s. Order of the Russian Federation Government to the Ministry of Economic Development. The Ministry of Health, 10.03.2015. (Russian).
14. Skvortsova VI. Report on the Scientific Forum of the IAEA. 19 Sep. 2018 [Electronic resource] https://www.rosmindrav.ru/news/2017/09/19/6110-vystuplenie-ministra-zdravoohraneniya-rossiyskoy-federatsii-v-i-skvortsovoy-na-na-nauchnom-forume-magate (date of the application 15.10.2018). (Russian).
15. Uiba VV, Samoylov AS, Zabelin MV. Nuclear technology in medicine. Report on the 1-st State Congress RATRO The innovation technologies in radiotherapy and nuclear medicine. Development prospects. 2017; 104. (Russian)
16. Tulskaya TI. Radiopharmaceuticals for diagnostic. Target Projects in Medicine. 2012; 12: [Electronic resource]: http://www.sovstrat.ru/journals/medicina-celevye-proekty/articles/st-med12-20.html (date of the application 15.10.2018). (Russian)
17. Danilova T. Heavy Ionic Artillery // [Electronic resource]: http://www.atomiexpert.com/page 298820.html (date of the application 15.10.2018). (Russian).
18. The concept of implementation of a pilot project for the creation of regional research and production nuclear medical clusters. LLC “The Center of Nuclear Medicine” – Stateorder. (Russian).
19. Kirienko SV. The future will be for nuclear medicine // Medicine: target projects. 2011;(10):20-1. (Russian).
20. Passport of the Innovation Development and Technological Modernization Program of “ROSATOM” until 2020 (in the Civilian Part). (Russian).
For citation: Uiba VV, Udalov YuD, Lebedev AO, Shulepova LI. Prospects for Implementing of Technologies of Nuclear Medicine in the FMBA of Russia. Medical Radiology and Radiation Safety. 2019;64(2):5-10. (Russian).
PDF (RUS) Full-text article (in Russian) Medical Radiology and Radiation Safety. 2012. Vol. 57. No. 5. P. 72-82
REVIEW
L.M. Rozhdestvensky
Radiation Countermeasures (Protection and Therapy): Modern Statement, Problems and Prospectives
Burnasyan Federal Medical Biophysical Center of FMBA, Moscow, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
In Russia radiobiological invesigations there are 2 actual directions of studying pharmacological radiation countermeasures according to real radiation accident scenarios. The first one is effectiveness increasing the severe radiation injury therapy. Another one is searching a radioprotector of prolonged action that would capable to protect against the prolonged radiation exposure of low radiation rate.
On the first direction there is a real possibility to increase effectiveness of the world consensus treatment protocol regarding severe human radiation injuries by means of the home preparation betaleukine usage as a means of the urgent therapy. In experiments on dogs it has been shown that a single s/c betaleukine injection in limits 2 h after lethal radiation exposure is as effective as the G-CSF 3 week course.
At the same time there is a crisis concerning progress in solving such problems as an elaboration of a radioprotector against prolonged low dose rate exposure, a revealing an indicator/ marker of the pharmacologically increased radioresistance (dissolving the problem of the clinical trial 2nd phase realization regarding radioprotectors), the radioprotectors broad usage in a praxis of radiochemotherapy.
Western countries excel now Russia in elaborating new approaches and new preparations in radiation countermeasures, especially in mastering recombinant cytokines and their combinations.
Prospectives in overcoming crisis regarding radiation countermeasures investigations lie in the expansion of genomics and proteomics studies, in knowing intracellular signaling pathways regarding as ionizing radiation as radiation countermeasures action. It is necessary also to modify the radiation countermeasures studying in a way of cell and genomic tests use besides the survival test.
Key words: radiation countermeasures, radioprotectors, antiradiation therapy means, prolonged action radioprotectors, radiation injury scenarios, elevated radioresistance indicators
Medical Radiology and Radiation Safety. 2012. Vol. 57. No. 5. P. 58-65
NUCLEAR MEDICINE
V.D. Zavadovskaya, A.P. Kourazhov, O.Yu. Kilina, I.E. Gerbek, Z.A.Mayevskaya, M.A. Zorkaltsev
199Tl-Chloride-Scintigraphy in Diagnostics of Neoplastic Processes in Lungs and Mediastinum
Siberian State Medical University, Tomsk, Russia, e-mail This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: Assessment of 199Tl-chloride scintigraphy efficiency in diagnostics of lungs and mediastinum neoplastic processes.
Material and methods: Patients with lungs and mediastinum tumors or inflammations were undergone 199Tl-chloride scintigraphy in early and delayed phases (15 males and 17 females, 33 localizations).
Results: Sensitivity, specificity, positive and negative predictive values and accuracy in the nonspecific indications of the tumor processes were 77.3, 63.6, 81.0, 58.3 and 72.7 %, respectively. Causes of the false negative results were tumors less 2 cm or some histological types of them. Specificity of this method in diagnostics of tumors was increased by the quantitative criteria of RI > –0.199(ER)+1.169. In total, sensitivity, specificity, positive and negative predictive values, and accuracy of the tumor diagnostics in lung and mediastinum were 77.3, 100, 100, 68.8 and 84.8 %, respectively.
Conclusion: 199Tl-chloride scintigraphy may be used successfully for indication of lung and mediastinum tumors of more than 2 cm size. The specificity of 199Tl-chloride scintigraphy was increased by considering the different pharmacokinetics of this marker in the tumor and inflammatory focuses.
Key words: 199Tl-chloride scintigraphy, neoplastic processes, retention index, radionuclide diagnostics, diagnostic efficiency
Medical Radiology and Radiation Safety. 2012. Vol. 57. No. 5. P. 66-71
RADIATION PHYSICS, TECHNOLOGY AND DOSIMETRY
V.V. Kalashnikov, L.A. Naumova, E.V. Rabinkova, O.V. Shishkova
Sterility of Medical Devices after Irradiation and Sterility Test in A.I. Burnazyan FMBC in 2007-2009 years
Burnasyan Federal Medical Biophysical Center of FMBA, Moscow, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: To determine the sterility of medical devices that have passed irradiation and sterility test in Burnazyan FMBC.
Material and methods: Measurement presterilization contamination and sterility test sample production batch of products are held in FMBC methods established for the state supervision over the production of radiation-sterilized products, taking into account the species composition of micro flora, which gave rise during incubation, and if there is evidence that sterilization in approved production batch mode.
Results: The direct measurement of acceptance microbiological contamination presterilization, sterilization and sterility test were parts of the production of sterile products. Actually received the product to be sterilized with contamination presterilization 104-105 CFU. It is for these major items is set dose products in the series. The probability of presence of microorganisms capable of division in medical products, which passed in 2007-2009 years of exposure and tests for sterility in FMBC, less than 1x10-6.
Conclusion: The quality of sterilization products irradiated in FMBC beyond the quality of sterilization of products in health care settings. If the mode of sterilization approved, for direct microbiological acceptance of goods of an opportunity to customize the incubation period - seven days and a single medium, provided that it is universal for the cultivation of aerobic and anaerobic bacteria.
Key words: sterilization, medical products, quality of sterilization, test for sterility, presterilization contamination
Medical Radiology and Radiation Safety. 2012. Vol. 57. No. 5. P. 54-57
NUCLEAR MEDICINE
Yu.B. Lishmanov1, N.G. Krivonogov1, T.S. Ageeva2, K.V. Zavadovskiy1, A.V. Dubodelova2
Scintigraphic Peculiariries of Lung Affection in Case of Bronchial Asthma
1. Institute of Cardiology of Tomsk Research Center of the RAMS, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. ; 2. Siberian State Medical University, Tomsk, Russia
Abstract
Purpose: To determine typical scintigraphic signs of ventilationperfusion disorders for bronchial asthma. Material and methods: 20 patients with the verified diagnosis of bronchial asthma at the stage of remission and 10 healthy non-smoking volunteers took part in the study. All the examined subjects underwent ventilation-perfusion lung scintigraphy.
Results: Bronchial asthma patients have positive bilateral increase of the apical-basal gradient of perfusion, reduction of the apical-basal gradient of ventilation and acceleration of alveolar-capillary permeability during the 30th minute of the study as compared to the analogues rates of healthy individuals.
Conclusion: The data received testify to the fact that the scintigraphic assessment of alveolar-capillary permeability of lungs as well as the evaluation of apical-basal gradients of ventilation and perfusion can be used as additional criteria to diagnose bronchial asthma at early stages.
Key words: ventilation-perfusion lung scintigraphy, bronchial asthma, apical-basal gradient of perfusion and ventilation, alveolar-capillary permeability